Regadenoson 43598-0616
Product NDC
43598-0616- Manufacturer
- Dr. Reddy's Laboratories Inc.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 23, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA213210
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson Anhydrous | .08 mg/mL |
Drug Class
Pharmacologic Cardiac Stress Test Agent [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
5 mL in 1 CARTON (43598-616-11)